Nektar Therapeutics (NKTR)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $11.18M in the quarter ending June 30, 2025, a decrease of -52.42%. This brings the company's revenue in the last twelve months to $74.93M, down -19.56% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.

• Revenue (ttm): $74.93M
• Revenue Growth: -19.56%
• P/S Ratio: 10.32
• Revenue / Employee: $1,228,426
• Employees: 61
• Market Cap: 1.05B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	98.43M	8.31M	9.22%
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.